Fig. 5From: Hyaluronic acid spacer in prostate cancer radiotherapy: dosimetric effects, spacer stability and long-term toxicity and PRO in a phase II studyA GI toxicity (RTOG) and patient reported outcome (measured with the question "Do you have problems with your stool?"). B GU toxicity (RTOG) and patient reported outcome (measured with the question "Do you have problems with your urinary tract?")Back to article page